Trellus Health (TRLS.L) Action Cours

Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan and currently employs 31 full-time employees. The company went IPO on 2021-05-28. The company offers a scientifically validated, personalized resilience-based self-management training program for people living with chronic conditions. The company is focused on the intersection of chronic physical conditions and mental health. The Company’s approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, primarily focused on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and irritable bowel syndrome (IBS). The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Company’s wholly owned subsidiary is Trellus Health Inc.